Cos Cob, CT, United States of America

Richard J Bucala

USPTO Granted Patents = 57 

 

 

Average Co-Inventor Count = 2.4

ph-index = 22

Forward Citations = 991(Granted Patents)

Forward Citations (Not Self Cited) = 956(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • New York, NY (US) (1997 - 2006)
  • New Haven, CT (US) (2020)
  • Greenwich, CT (US) (2020)
  • Cos Cob, CT (US) (1998 - 2023)

Company Filing History:


Years Active: 1997-2023

Loading Chart...
Loading Chart...
Loading Chart...
57 patents (USPTO):

Title: Richard J Bucala: Pioneering Innovations in Medical Research

Introduction

Richard J Bucala is an accomplished inventor based in Cos Cob, CT, USA, known for his significant contributions to the field of medical research. With an impressive portfolio of 57 patents, Bucala has dedicated his career to developing novel therapeutic strategies addressing critical health issues through innovative approaches.

Latest Patents

Among his latest inventions, Bucala has developed MIF modulators, which involve novel heterocyclic compounds and pharmaceutical compositions aimed at modulating levels of MIF (macrophage migration inhibitory factor) expression. This invention has implications for treating disorders associated with abnormal MIF levels. Another key patent focuses on the uses of parasite macrophage migration inhibitory factors, relating to compositions, such as vaccine formulations, that provide protective immunity against parasitic infections. These compositions comprise nucleic acids encoding MIF antigens, parasite MIF antigens, or antibodies binding specifically to these antigens, showcasing Bucala’s innovative approach to combating diseases caused by parasitic protozoans and helminths.

Career Highlights

Throughout his career, Richard J Bucala has worked with prestigious institutions including The Picower Institute for Medical Research and Yale University. His research has significantly advanced the understanding of immune responses and their roles in various diseases, particularly those related to parasitic infections.

Collaborations

Bucala has collaborated with notable scientists, including Anthony Cerami and Helen Vlassara, contributing to a dynamic exchange of ideas and fostering advancements in the medical research community. These collaborations have resulted in impactful innovations that continue to enhance therapeutic strategies in immunology and infectious diseases.

Conclusion

In summary, Richard J Bucala's extensive patent portfolio and collaborative efforts illustrate his commitment to innovation in medical research. His inventions continue to pave the way for new treatments for disorders influenced by MIF expression, making a lasting impact on the field of healthcare and biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…